HUP0203369A3 - Polycycloalkylpurines as adenosine receptor antagonists, process for their preparation and their use - Google Patents

Polycycloalkylpurines as adenosine receptor antagonists, process for their preparation and their use

Info

Publication number
HUP0203369A3
HUP0203369A3 HU0203369A HUP0203369A HUP0203369A3 HU P0203369 A3 HUP0203369 A3 HU P0203369A3 HU 0203369 A HU0203369 A HU 0203369A HU P0203369 A HUP0203369 A HU P0203369A HU P0203369 A3 HUP0203369 A3 HU P0203369A3
Authority
HU
Hungary
Prior art keywords
polycycloalkylpurines
preparation
receptor antagonists
adenosine receptor
adenosine
Prior art date
Application number
HU0203369A
Other languages
Hungarian (hu)
Original Assignee
Biogen Idec Ma Inc Cambridge
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biogen Idec Ma Inc Cambridge filed Critical Biogen Idec Ma Inc Cambridge
Priority claimed from PCT/US2000/031058 external-priority patent/WO2001034610A1/en
Publication of HUP0203369A2 publication Critical patent/HUP0203369A2/en
Publication of HUP0203369A3 publication Critical patent/HUP0203369A3/en

Links

HU0203369A 1999-11-12 2000-11-13 Polycycloalkylpurines as adenosine receptor antagonists, process for their preparation and their use HUP0203369A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6519199P 1999-11-12 1999-11-12
PCT/US2000/031058 WO2001034610A1 (en) 1999-11-12 2000-11-13 Polycycloalkylpurines as adenosine receptor antagonists

Publications (2)

Publication Number Publication Date
HUP0203369A2 HUP0203369A2 (en) 2003-01-28
HUP0203369A3 true HUP0203369A3 (en) 2004-12-28

Family

ID=22060947

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0203369A HUP0203369A3 (en) 1999-11-12 2000-11-13 Polycycloalkylpurines as adenosine receptor antagonists, process for their preparation and their use

Country Status (1)

Country Link
HU (1) HUP0203369A3 (en)

Also Published As

Publication number Publication date
HUP0203369A2 (en) 2003-01-28

Similar Documents

Publication Publication Date Title
HUP0301671A3 (en) 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists, process for their preparation and their use
HUP0202810A3 (en) Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof as adenosine receptor ligands, process for their preparation and pharmaceutical compositions containing them
HUP0201033A3 (en) Glucagon antagonists/inverse agonists, process for their preparation and their use
IL152726A0 (en) Adenosine a2a receptor antagonists
GB9823873D0 (en) 2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
HUP0203425A3 (en) Quinazoline derivatives, process for their preparation and their use
IL147198A0 (en) N-pyrazole a2a receptor agonists
IL147195A0 (en) C-pyrazole a2a receptor agonists
HUP0202202A3 (en) Benzoxepino [2,3-b]pyridine derivatives and analogues as chemokine receptor antagonists and the use thereof
GB9911053D0 (en) 4,5,6,7-tetrahydroindazole derivatives process for their preparation and their use as antitumour agents
MXPA03004439A (en) Aminothiazoles and their use as adenosine receptor antagonists.
HUP0401777A3 (en) 3h-[1,2,4]triazolo[5,1-i]purin-5-yl amines as adenosine a2a receptor antagonists and pharmaceutical compositions containing the compounds
HUP0200409A2 (en) Valdecoxib compositions, process for their preparation and their use
HK1063780A1 (en) Adenosine a2a receptor antagonists
IL161572A0 (en) Adenosine a2a receptor antagonists
HK1064097A1 (en) Bicyclic Ä1,2,4Ü -triazole adenosine a2a receptor antagonists
PL356990A1 (en) Isoxazolecarboxamide derivatives as alpha1-adrenergic receptor antagonists
HUP0203385A3 (en) Pyrimidine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0201571A3 (en) Il-8 receptor antagonist phenyl urea derivatives, process for the preparation thereof and pharmaceutical compositions containing them
HUP0203371A3 (en) Adenosine receptor antagonists and methods of making and using the same
GR3033415T3 (en) (Aminoalkyl- and acylaminoalkyl-oxy)benzyloxyquinolines, process for their preparation and use as Bradykinin receptor antagonists
HUP0104804A3 (en) Tetrahydro-naphthyridinyl derivative as vitronectin receptor antagonist, process for its preparation and pharmaceutical composition containing the same
PL351794A1 (en) 4-heterocyclysulfonamidyl-6-methoxy-5-(2-methoxy-phenoxy)-2-pyridyl-pyrimidine derivatives, their preparation and use as endothelin receptor antagonists
PL370565A1 (en) 5-methoxy-8-aryl-[1,2,4] triazolo [1,5-a] pyridine derivatives as adenosine receptor antagonists
HUP0102011A3 (en) Macrolide lhrh antagonists and their use, process for preparing them and pharmaceutical compositions comprising the salds compounds

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees